KF 66854

Drug Profile

KF 66854

Latest Information Update: 14 Feb 2006

Price : $50

At a glance

  • Originator Kyowa Hakko
  • Class Irritable bowel syndrome therapies; Small molecules
  • Mechanism of Action Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Dyspepsia; Inflammatory bowel diseases

Most Recent Events

  • 14 Feb 2006 No development reported - Preclinical for Inflammatory bowel disease in Japan (unspecified route)
  • 14 Feb 2006 No development reported - Preclinical for Dyspepsia in Japan (unspecified route)
  • 13 May 2002 A preclinical study has been added to the Digestive System Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top